Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 0.00% is 100% above its 5-year average of -737.21%, near the high end of its 5-year range (-1986.53%–0.00%).
As of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly operating margin; no daily interpolation. Q4 FY2025 (2025-12-31): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
-336.83%
OPERATING MARGIN AVG 5Y
-737.21%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+100.00%
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 845 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Niki BioSolutions, Inc.
Market Cap
$381940.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-336.83%
5Y Avg
-737.21%
Market Cap
$380715.00
Operating Margin
-51515.17%
TTM Avg
-74429.96%
3Y Avg
-54994.21%
5Y Avg
-36749.57%
Market Cap
$483178.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$522716.00
Operating Margin
-8567.94%
TTM Avg
-8664.53%
3Y Avg
-8990.40%
5Y Avg
-6121.14%
Market Cap
$243502.00
Operating Margin
-1022.08%
TTM Avg
-791.13%
3Y Avg
-582.66%
5Y Avg
-578.16%
Market Cap
$552784.00
Operating Margin
-20757.65%
TTM Avg
-10953.08%
3Y Avg
-5758.86%
5Y Avg
-3862.92%
Market Cap
$109148.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$669763.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$96426.00
Operating Margin
N/A
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Niki BioSolutions, Inc. (NIKI) | $381940.00 | 0.00% | 0.00% | -336.83% | -737.21% |
| Virax Biolabs Group Limited (VRAX)vs › | $380715.00 | -51515.17% | -74429.96% | -54994.21% | -36749.57% |
| XORTX Therapeutics Inc. (XRTX)vs › | $483178.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| VivoSim Labs, Inc. (VIVS)vs › | $522716.00 | -8567.94% | -8664.53% | -8990.40% | -6121.14% |
| SciSparc Ltd. (SPRC)vs › | $243502.00 | -1022.08% | -791.13% | -582.66% | -578.16% |
| HCW Biologics Inc. (HCWB)vs › | $552784.00 | -20757.65% | -10953.08% | -5758.86% | -3862.92% |
| Silexion Therapeutics Ltd. (SLXN)vs › | $109148.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| CDT Equity Inc. (CDT)vs › | $669763.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Psyence Biomedical Ltd. (PBM)vs › | $96426.00 | N/A | 0.00% | 0.00% | 0.00% |
| PRF Technologies Ltd. (PRFX)vs › | $72785.00 | -29335.29% | -14667.65% | -9912.02% | -6608.01% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-06-30 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-06-30 | -1515.84% |
| 2022-12-31 | -1178.77% |
| 2022-06-30 | -1602.39% |
| 2021-12-31 | -1074.45% |
| 2021-06-30 | -1488.59% |
| 2020-12-31 | -1986.53% |
| 2020-06-30 | -2532.75% |
| 2019-12-31 | -3382.15% |
| 2019-06-30 | -3422.97% |
| 2018-12-31 | -2693.44% |
| 2018-06-30 | -18285.82% |
